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The interaction between diet and gut microbiota, and ultimately their link to health, has become 
the focus of huge research showing that diet and lifestyle have a strong influence on the gut 
microbiota. That is why there is a growing interest in resolving questions about the relation 
between the gut microbiome and host metabolism. 
  
The human intestine is densely populated by trillions of microbial symbionts. The symbiotic gut 
microbiota helps nutrient absorption through the fermentation of dietary fibre, provides 
protection from invading pathogens and helps to develop and regulate the immune system. 
However, the mechanisms underlying interactions between diet, gut microbiome and host 
metabolism are still poorly understood. Here, we discuss how meta-omics datasets can be 
obtained through an in vitro model model of colonic fermentation in order to study how the food 
that is consumed can shape the diversity and composition of the gut microbiota. In order to 
analyze microbial community structure, tools and approaches such as next generation 
sequencing (NGS) of 16S rRNA amplicons and bioinformatic analysis are used. The study will 
be performed with bread that will be digested and then submitted to an in vitro fermentation 
process with fecal inocula from healthy Spanish adults from Granada.  
  
In the end, the influence of bread on the structure of the gut microbiota from different types of 
fecal samples will be evaluated, as well as the variability of the microbioal taxonomy, 
composition and alpha and beta diversity when fecal samples are analyzed before and after 
fermentation and before and after a freezing treatment at -80 Cº. Our results suggest that despite 
a loss of bacterial groups that alters the microbial composition, freezing the samples before 
fermentation is not a serious problem because the effect of fermentation on the samples remains 
significant in terms of richness, diversity and abundance of the main bacterial groups. This will 
be studied in line with the main objectives of a larger project (Stance4Health) of developing a 
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La interacción entre la dieta y la microbiota intestinal, y finalmente su vínculo con la salud, se 
ha convertido en el foco de una gran investigación que demuestra que la dieta y el estilo de vida 
tienen una gran influencia en la microbiota intestinal. Es por eso que hay un interés creciente en 
resolver las preguntas sobre la relación entre el microbioma intestinal y el metabolismo del 
huésped. 
 
El intestino humano está densamente poblado por billones de simbiontes microbianos. La 
microbiota intestinal simbiótica ayuda a la absorción de nutrientes a través de la fermentación 
de la fibra dietética, proporciona protección contra patógenos invasores y ayuda a desarrollar y 
regular el sistema inmunológico. Sin embargo, los mecanismos subyacentes a las interacciones 
entre la dieta, el microbioma intestinal y el metabolismo del huésped aún no se conocen bien. 
Aquí, discutimos cómo los conjuntos de datos meta-ómicos se pueden obtener a través de un 
modelo in vitro de fermentación colónica para estudiar cómo los alimentos que se consumen 
pueden dar forma a la diversidad y composición de la microbiota intestinal. Con el fin de 
analizar la estructura de la comunidad microbiana, se utilizan herramientas y enfoques como la 
secuenciación de la próxima generación (NGS) de los amplicones del ARNr 16S y el análisis 
bioinformático. El estudio se realizará con pan que se digerirá y luego se someterá a un proceso 
de fermentación in vitro con inóculos fecales de adultos sanos españoles (Granada). 
 
Al final, se evalua influencia del pan sobre la estructura de la microbiota intestinal de diferentes 
tipos de muestras fecales, así como en la variabilidad de la taxonomía microbiana, la 
composición, y la diversidad alfa y beta cuando las muestras fecales se analicen antes y después 
de la fermentación y antes y después del tratamiento de congelación a -80ºC. Nuestros 
resultados sugieren que a pesar de la pérdida de grupos bacterianos que altera la composición 
microbiana, congelar las muestras antes de la fermentación no es un problema grave debido a 
que seguimos vienod el efecto de la fermentación en las muestras en términos de riqueza, 
diversidad y abundancia de los principales grupos bacterianos. Esto se estudiará de acuerdo con 
los objetivos principales de un proyecto más grande (Stance4Health) de desarrollar un sistema 
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1. INTRODUCTION  
 
Over the last two decades, microbiome analysis of faecal samples using culture-independent 
methods, such as high-throughput DNA sequencing has emerged as a non-invasive tool to study 
nutrition and health and this has enabled researchers to explore the interaction between diet and 
gut microbiota (Jain et al., 2018).  
 
The gut microbiome acts as an auxiliary metabolic organ and harbours a densely populated 
microbial ecosystem containing a number of bacterial cells that is larger than the number of 
eukaryotic cells in the entire human body, and including trillions of microorganisms such as 
bacteria, archaea, viruses and unicellular eukaryotes.  Most gut microbes are facultative obligate 
anaerobes spanning five different phyla (Bacteroidetes, Firmicutes, Proteobacteria, 
Verrumicrobia, and Actinobacteria), with over 1000 species already identified (Claesson et al., 
2009). The composition of the gut microbiota is relatively simple at birth, and it undergoes a 
series of changes in composition and metabolic functions until it eventually matures between 3–
5 years of age (Rodriguez, et al., 2015). For any healthy adult individual, the composition of the 
gut microbiome tends to be stable over time but there are differences in the composition of the 
gut microbiome within a human population depending, among other factors on the foods they 
consumed (Faith et al., 2015) 
 
Regarding the function of the colon, it is the major site for the gut microbiota “co-metabolic” 
activity, which enhances the efficiency of energy harvest from foods and influences the 
synthesis, bioavailability and function of nutrients. This activity produces different beneficial 
compounds that regulate host health, such as Short Chain Fatty Acids (SCFAs), polyphenol 
metabolites, neuroactive chemical species, etc. This leads us to view ourselves as “supra-
organisms”, composed of our cells and of microbial cells depending on each other for survival 
(Proposal Stance4health). What's more, the gut microbiota plays a primary function in host 
health by shaping the development of the immune system, metabolizing dietary nutrients and 
drugs, and synthesizing vitamins, bioactive molecules, and other beneficial or detrimental 
metabolites. For example, several complex carbohydrates, not digested by the host intestinal 
enzymes, are passed to the microbial community, which are then metabolized in the large 
intestine (Ji et al., 2015). As it has been said, the gut microbiota is involved in metabolism of 
short-chain fatty acid (SCFAs), but also involved in the processing of branched chain fatty acids 
(BCFAs), branched chain amino acids (BCAAs), biogenic amines, vitamins, bile acids (BAs), 
and xenobiotics, as well as the production of gases (e.g., CO2, CH4). (Lamichhane et al., 2018).  
 
Moreover, gut microbes also affect the host immune system, such as by regulating immune 
homeostasis versus autoimmunity (Napier et al., 2019) inducing toll-like receptor (TLR) 
expression, antigen presenting cells (APCs), and differentiated CD4+ T cells (Valentini et al., 
2014) and maintaining the stability of the immune system by providing resistance against 
pathogens. (Sen et al., 2019). This can be linked to the fact that the gut microbiota is directly 
related to health and disease and it has been proved that imbalance in the gut microbiota has 
been associated with inflammatory and metabolic disorders including inflammatory bowel 
disease (Frank et al. 2007), irritable bowel syndrome, and obesity (Claesson et al. 2012). 
1.1 FUNCTIONS AND COMPOSITION OF THE HUMAN MICROBIOME 
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Changes in the composition of the gut microbiota flora have also been associated with 
autoimmune diseases such as type 1 diabetes (T1D) and rheumatoid arthritis, colon cancer 
(Sears et al., 2014), type 2 diabetes (T2D), obesity (Shoaie et al., 2015), cardiovascular 
disorders (Jonsson et al., 2017), non-alcoholic fatty liver disease (NAFLD) (He et al., 2016) or 
inflammatory bowel disease (IDB) (Wlodarska et al., 2015). Current evidence thus makes 
Hippocrates’ statement “All disease begins in the gut”, more convincing today than ever before 
and shows that the changes in the diet impacted our microbial symbionts, possibly playing a role 
in the development of several diseases. 
 
 
Several genetic and environmental factors such as diet, lifestyle, geography, mode of delivery, 
infection, infant feeding modality and medication shape the gut microbiota during the early 
stages of life (Schmidt et al., 2018). However, the gut microbiota can be rapidly affected by 
diet, one of the main factors that modify its taxonomic diversity and modulate the 
microorganisms’ proportions. So, while genetics, mode of delivery at birth, physical 
environment, age, stress, and other factors can influence the dynamics of the gut microbiota, 
diet may be the single most important driver of gut bacterial composition and function. The 
development of the infant microbiome is dependent on various factors, such as infant feeding 
method, diet and the environment (Figure 1). Also, the mode of delivery (either vaginal or by 
cesarean section) affects the early life microbiome. Transfer of bacteria from the mother to the 





Figure 1. Development of the gut microbiome during infancy. 
(Mohajeri et al., 2018) 
 
 
That is why it is important to unravel the specific effects of foodstuffs from different groups like 
vegetables, fruits, meat, legumes, or cereals and how different types of food modify the 
microbial diversity in our gut, taking into consideration that the ability of the gut microbiota to 
use substrates could also be influenced by the culinary heat treatment undergone by the 
foodstuffs prior to ingestión or how the fermentation occurred (Pérez-Burillo et al., 2018). 




Although nutrition research has focused on how direct interactions between dietary components 
and host systems influence human health, it is becoming increasingly important to consider 
nutrient effects on the gut microbiome for a more complete picture and it is crucial to 
understand nutrient-host-microbiome interactions to reveal novel mechanisms of disease 
etiology and progression, in order to accomplish prevention strategies and to evaluate the safety 
of food ingredients (Sheflin et al., 2017) and their impact in the human gut. Thus, targeted 
modulation of the gut microbiota will need to be a key element of a future Smart Personalised 
Nutrition (SPN) (Johson et al., 2019) 
 
Numerous studies have shown that vegetarians compared to omnivores following a western diet 
exhibit a lower risk for various chronic diseases including obesity, hypertension, dyslipidaemia, 
coronary heart disease, stroke, diabetes, and certain cancers. 
 
While vegetarians likely benefit from other health-related behaviours associated with lower 
disease risk, experimental studies that attempt to control for such confounders still show that 
changing from a western to a vegetarian dietary pattern reduces a number of disease risk factors 
(De Filippis et al., 2018). Lower intakes of total fat, saturated fatty acids, dietary cholesterol, 
and animal proteins among vegetarians are thought to be important features of this dietary 
pattern linked to lower risk for chronic disease. Regarding the gut microbiota, vegetarians 
compared to omnivores tend to exhibit greater bacterial diversity and richness and greater ratios 
of Prevotella to Bacteroides. Global macronutrient profiles can modulate the intestinal 
microbiota: saturated fat and animal protein decrease microbial diversity and enrich for 
Bacteroidetes and Actinobacteria, whereas plant-based diets with high content of carbohydrates 
increase microbial diversity, linked with Firmicutes and Proteobacteria (Bisanz et al., 2019).  
 
Moreover, it has been seen that a strict vegetarian diet leads to a decrease in pathobionts such as 
the Enterobacteriaceae and an increase in commensal microbes such as Bacteroides fragilis and 
Clostridium species resulting in reduced intestinal lipocalin-2 and short-chain fatty acids levels. 
The results indicate that a strict vegetarian diet (SVD) had a significant effect on the 
composition of the gut microbiota at the operational taxonomic unit (OTU) level. However, 
there was no correlation between the consumption of an SVD and bacterial diversity. An SVD 
also reduced body weight and the concentrations of triglycerides, total cholesterol, low-density 
lipoprotein cholesterol and haemoglobin A1c, and improved fasting glucose and postprandial 
glucose levels. Kim et al. (2013) underscores the benefits of dietary fibre for improving the risk 
factors of metabolic diseases and shows that increased fibre intake reduces gut inflammation by 
changing the gut microbiota (Kim et al., 2013). Thus, an intake of dietary fibre is thought to 
reduce the risk for obesity and metabolic diseases by modulating the composition of the gut 
microbiota.  
 
Both Bacteroides and Prevotella have already been reported as usually present in the human gut 
regardless of nationality or continental geography. Bacteroides was the most plentiful genus 
detected in the gut microbiota of those who consumed Western-style-food containing high 
1.3 TOWARDS PERSONALISED NUTRITION 
1.4 DIFFERENT DIETS THAT AFFECT THE MICROBIOME    
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protein and animal fat, whereas Prevotella was the most abundant genus in the gut microbiota of 
those who usually consumed a carbohydrate-enriched diet (Claesson et al., 2012). Carbohydrate 
fermentation results in an increased concentration of short-chain fatty acids, which in turn cause 
a decrease in pH from 6.5 to 5.5. Bacteroides species grow poorly at pH 5.5. This may be the 
reason why a low abundance of Bacteroides was found in vegetarians.  
 
As it has been discussed, diet, microbiota, and the occurrence of disease are linked, therefore 
dietary modulation studies could provide valuable information to understand diet-microbiota 
health issues and be useful for medical application, as changing the host’s microbiota can lead 
to better health. It is suggested that the abundance of Bacteroides and Prevotella may be useful 
as a prognostic biomarker of disease in combination with other bacterial species from the core 
gut microbiota, especially Faecalibacterium prausnitzii (Ruengsomwong et al., 2016). 
 
As a result, it could be said that the gut microbiota composition changes rapidly in response to 
dietary adaptations and this is linked to health. For example, foods of animal origin contain 
higher amounts of choline and L-carnitine, which have been linked to higher risk for 
cardiovascular disease as a result of their conversion to trimethylamines by gut bacteria, 
absorption into portal circulation, and conversion to trimethylamine N-oxides (TMAO) in the 
liver. While the mechanisms by which TMAO increases cardiovascular risk need further 
clarification, it has been shown that TMAO reduces reverse cholesterol transport and bile acid 
(Wilson et al., 2013) synthesis, potentially attenuating the normal route of intestinal cholesterol 
elimination. Vegans and lacto-ovo vegetarians have been shown to have negligible postprandial 
plasma TMAO concentrations in response to an L-carnitine meal challenge (Koeth et al., 2013). 
This suggest reduction in carnitine and total choline ingestion with attendant reductions in 
TMAO levels may contribute to the cardiovascular health benefits observed in 
vegan/vegetarians. Thus it appears that the lower cardiovascular disease risk associated with a 
plant-based diet could result, in part, from lower circulating TMAO. 
 
To sum up, it could be said that the overall balance in the composition of the gut microbial 
community and the presence of key species are important in ensuring homeostasis of the 
intestinal ecosystem to enhance good health. 
 
 
Since gut microbiota can be easily affected by diet, it is important to unravel the specific effects 
of foodstuffs from different groups like vegetables, fruits, meat, legumes, or cereals, among 
others. However, the ability of gut microbiota to use substrates could also be influenced by the 
culinary heat treatment undergone by the foodstuffs prior to ingestion. 
 
Upon cooking, many different compounds will be generated, most of them derived from the 
Maillard reaction. All these neoformed compounds could have some effect over the gut 
microbiota (Pérez-Burillo et al., 2018). This is why cooking methods could play an important 
role in the modulation of the gut microbiota, due to chemical changes in foodstuffs during the 
cooking process. There are only few studies on this topic but Shen et al. (2010) for example 
found that fried beef increased the levels of Clostridium spp. and Bacteroides spp. more than 
boiled beef, while decreasing the levels of SCFAs. Marungruang et al. (2016) showed that a 
1.5 HOW THE WAY OF COOKING CAN AFFECT THE GUT MICROBIOTA 
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heat-treated diet rich in lipids alters the composition and functionality of the gut microbiota in 
mice and increases adiposity and low-grade inflammation, compared with the same diet not 
submitted to heat-processing. Heat processing transforms proteins, carbohydrates and lipids due 
to the Maillard reaction, lipid oxidation and others. These reactions produce new compounds, 
such as melanoidins, which can exert both antimicrobial and prebiotic activities. Therefore, one 
of the greatest challenges in nutrition is to interrogate the interactions existing within complex 
food matrices that integrate a wide range of biologically active compounds. This raises the 
question of whether there are specific dietary ingredients-nutrients that exert stronger selective 
forces on the diversity and functional configuration of microbial communities than others, and 
how different thermal processes affect their microbiota-modulating capacities.  
 
 
Nearly two billion people worldwide are overweight or obese (World Health Organization – 
WHO, 2017), which contributes to an increase in the incidence of Non-communicable disease 
(NCD) such as obesity, type 2 diabetes and metabolic syndrome kill approximately 38 million 
people each year (WHO, 2016).  The most common NCDs are cardiovascular disease, cancer, 
chronic respiratory disease, and diabetes. Almost a quarter of people currently employed suffer 
from some form of chronic disorder, including many that suffer from obesity, which in turn 
leads to substantial on-the-job productivity losses (UNEP, 2016). The prevalence of NCD in 
children is also alarming. Prevalence of overweight in children and adolescents has risen 
dramatically from 4% in 1975 to over 18% in 2016 (WHO, 2017). For example, in Germany 
15% of children and adolescents are overweight (Varnaccia et al., 2017) while 67% of men and 
53% of women are also overweight (Bohn et al., 2017). These children are at increased risk for 
physical problems, such as cardiovascular disease, diabetes and musculoskeletal disorders, as 
well as problems related to social and emotional wellbeing and self-esteem. Childhood 
overweight and obesity have been characterized by the WHO as one of the most serious public 
health challenges of the 21st century. While excessive energy intake and insufficient physical 
activity are the main drivers of childhood overweight and obesity, recent research has suggested 
that other factors such as the gut microbiota may also be involved as shown in Figure 2. The 
gut microbiota contributes to the development of overweight and a lower gut microbial richness 
and diversity is associated with obesity. Actually, obese individuals appear to harbour a high 
Firmicutes-to-Bacteroidetes ratio in their gut microbiota. 
 




Figure 2. Schematic of gut microbiota effects on risk factors for CVD and adverse cardiovascular events. 
(Ahmadmehrabi et al., 2017) 
 
However, it has been shown that weight-related parameters (BMI and weight z scores and 
overweight) are not major drivers of microbial composition in the gut of relatively lean, healthy 
children. Nonetheless, several specific bacterial taxa appear to be consistently associated with 
weight-related outcomes and linked to body weight, as well as novel species. Higher 
abundances of Prevotella oralis et rel. and P. melaninogenica et rel. were inversely associated 
with overweight and other bacterial groups, of which Akkermansia, Marvinbryantia 
formatexigens et rel., and Sutterella wadsworthensis et rel. were consistently associated with all 
three anthropometric outcomes such as height, weight and percentage body fat (Mbakwa et al., 
2018). 
In addition, other pathologies related with food are also expanding such as oeliac disease that 
occurs in about 1% of people in most populations. A true rise in incidence rather than an 
increased awareness and detection of the disease is considered (Lebwohl et al., 2017). On the 
other hand, food allergy has rapidly increased in prevalence over the last 30 years (up to 10% of 
the European population) and is characterized as a growing and threatening public health 
concern that can have a significant impact on the quality of life of children and their families. 
Therefore, an understanding of what constitutes a health-promoting or disease-promoting 
microbial group and of how this is related to diet has turned into the focus of huge research. 
 
 
The European Commission Recommendation “A healthy diet for a healthy life” (2010/250/EU) 
(http://www.stance4health.com) states that if common lifestyle risk factors, including diet-
related ones, were eliminated, around 80% of cases of heart disease, strokes and type 2 diabetes, 
and 40% of cancers, could be avoided. Personalised nutrition for the European population is 
seen as the way forward to tackle this challenge.  The Smart Personalised Nutrition approach 
proposed by Stance4Health will be tailored to different target groups, from healthy children and 
adults to children with coeliac disease or food allergy, as well as overweight children and adults, 
1.7 STANCE4HEATLH PROJECT 
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which will have an impact on the development of non-communicable diseases such as obesity or 
type 2 diabetes.  
  
In a first step, Stance4Health will develop a novel ICT application (the mobile app i-Diet as it is 
described in Figure 3) that will provide individualized counselling about what foods are more 
recommendable according to the overall needs/preferences of consumers (e.g., health status, gut 
microbiota composition, lifestyle, food preferences, and socio-economic status). In a second 
step, Stance4Health will develop customized cereal-derived foods, individualised dietary 
supplements and nutraceuticals for vulnerable target groups mentioned above (overweight, 
coeliac disease, food allergy), as well as an in vitro diagnostic test to evaluate gut microbiota 
activity and a wearable device to help users monitor their body weight over time. 
 
In conclusion, i-Diet will be designed as an innovative and easy tool ecosystem for dietary 
assessment, allowing measurement of dietary intake in an easy way. All of these technologies 
will be developed and integrated in Stance4Health by means of preparing an i-Diet prototype, 
testing new vegetable extracts to produce cereal-derived foods for the target groups and a large-
scale validation of all tools developed (mobile app, wearable, new foods and nutraceuticals, in 
vitro metabolomics diagnostic test). Importantly, i-Diet will have a strong focus on modulating 
the gut microbiota of an individual through comsumption of a personalised diet in order to 
improve metabolism and overall health. 
 
 






One of the initial aims of the SPN project Stance4Health is to characterize the bacterial taxa that 
define the community structure in gut samples from volunteers before and after in vitro 
fermentation assays with different types of foods. The food employed in the assays will first be 
digested in vitro with a protocol developed within the project INFOGEST, and the digested food 
will then be submitted to an in vitro fermentation process with fecal microbiome inocula from 
Spanish healthy adults, in total there are 11 samples. These experiments will be repeated with a 
large variety of foods in order to establish a database relating foods to gut microbiota changes; 
this database will represent an important part of the Stance4Health SPN system by contributing 
to the design of personalised diets that respond to the specific health needs of each individual.  
 
During the current work, one of the aims is supporting the validity of the experimental protocols 
that will be employed in the Stance4Health project before scaling up the project experiments. 
To achieve the aims of this study, the following specific objectives were stated: 
 
1) To employ 16S rRNA amplicon sequencing to detect gut microbiota alterations 
produced by the addition of food (bread) to a fecal inoculum in an in vitro fermentation 
assay following in vitro food digestion. 





3. MATERIALS AND METHODS  
 
Fecal samples were taken in sterile containers from three healthy Spanish adults, residing in 
Granada, with a normal body mass index and who had not taken antibiotics within the previous 
three months. At reception, each fecal sample was separated into three different tubes, one for 
immediate colonic phase in vitro fermentation (fresh feces), one to be stored at -80oC for 8 days 
without glycerol, and a last one to be stored at -80oC for 16 days before fermentation. There are 
6 different samples (S01-S06), with 2 copies of each one. 
 
 
Fermentation assays were performed at the University of Granada in the research group of Prof. 
José Angel Rufián Henares. Three in vitro fermentation experiments were performed, 
employing fresh feces, 8-days frozen feces and 16-days frozen feces. For each experiment, a 
pooled inoculum was prepared from the fecal samples of the three donors in order to perform a 
single experiment controlling for inter-individual variability. 
 
o Inocula preparation: each inoculum contains 3 g of feces/10 mL of phosphate buffer 0.1 
M pH 7 (1 g of feces from each donor). Fecal material and buffer are mixed by 
vortexing and centrifuged at 500 rpm for 10 minutes to remove solid particles but not 
bacteria. Two aliquots of the prepared inoculum are stored for 16S rRNA sequencing, 
and the rest is used for the in vitro fermentation. 
 
o These in vitro fermentations are carried out in falcon tubes. Each tube contains 2 mL of 
inocula, 7.5 mL of fermentation minimum medium (peptone, cysteine, and sodium 
sulfide), and 0.5 g of food. In vitro fermentation proceeds at 37oC for 20 hours in 
oscillation. 
 
o After 20 hours of incubation, two 1 mL samples of the fermentation medium were 
collected and centrifuged to pellet the bacterial cells. The pellets were frozen at -80oC 
and subsequently lyophilized for 3 hours before sending to FISABIO (Valencia) for 
DNA extraction, 16S rDNA gene amplification and sequencing. 
 
Microbiota was characterized before and after fermentation with the fresh feces (day 0), with 8-
days frozen feces and 16-days frozen feces. In vitro colonic fermentation was simulated with 




3.1 SAMPLING  
3.2 INOCULA PREPARATION AND IN VITRO FERMENTATION 
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Microbial DNA extraction from lyophilized stool samples (100-200 mg) was performed 
automatically using the MagNA Pure LC 2.0 robot (Roche) and with the MPLC DNA Isol 
extraction Kit III for bacteria (Roche), following the manufacturer's instructions. The extraction 
is carried out by the use of magnetic beads technology. In order to optimize microbial load, 1,5 
ml of PBS was added to the samples and these were centrifuged at 2.000 rpm for 3 min.  After 
this, the solid was discarded because the interesting part is the supernatant that is centrifuged 
again but now at 13.000 rpm in order to recover the bacteria from the new pellet at the bottom 
of the eppendorf, were the gut microorganisms are settled. 
 
Following the protocol, the extraction is done in the MagNA Pure LC 2.0 robot. 207 µl of lysis 
buffer and 23 µl of lisozyme (to break down the gram positive bacteria membranes) were added 
to the pellet. After vortexing the mix, the tube is incubated at 37 ºC for 30 min and in the final 
step before extraction, 20 µl of proteinase K were added to break down the proteins and free the 
microbial DNA. The tube was incubated 15 min at 65 ºC and 5 min at 95 ºC with proteinase K 
before loading the samples in the extraction robot 
 
Metagenomic studies are commonly performed by analyzing the prokaryotic 16S ribosomal 
RNA gene (16S rRNA), which is approximately 1,500 bp long and contains nine variable 
regions interspersed between conserved regions. Variable regions of 16S rRNA are frequently 
used for taxonomic classification of bacteria in diverse microbial populations and this will help 
us to see the taxonomic differences between samples. 
 
To date, the majority of gut microbiome studies have employed 16S rRNA gene amplification 
for microbial genotyping. 16S rRNA is a powerful phylogenetic marker and has become a 
standard in bacterial taxonomic classification because it is easily and rapidly sequenced and 
contains enough phylogenetical information. Some of the advantages are that it is universally 
distributed, can be used to measure phylogenetic relationships across different taxa, horizontal 
gene transfer isn´t a big problem and analysis costs are low. However, the technique 
incorporates systematic biases, is sensitive to 16S rRNA gene copy-number variations, and 
overinflates diversity estimates. Moreover, sometimes it is difficult to differentiate between 
closely related species and the variability in PCR amplification could affect the resultant data. In 
contrast, shotgun metagenomics sequencing is a non-targeted DNA-based approach that does 
not incorporate amplification biases. 
 
Which 16S rRNA region to sequence is an area of debate, and our region of interest might vary 
depending on things such as experimental objectives, design, and sample type. This protocol 
describes a method for preparing samples for sequencing the variable V3 and V4 regions of the 
16S rRNA gene, combined with the Illumina technology MiSeq benchtop sequencing system. 
MiSeq provides a comprehensive workflow for 16S rRNA amplicon sequencing. 16S rDNA 
gene amplicons were obtained following the 16S rDNA gene Metagenomic Sequencing Library 
Preparation Illumina protocol (Cod. 15044223 Rev. A). The gene specific sequences (Table 1) 
used in this protocol target the 16S rDNA gene V3 and V4 regions and are designed with 
Illumina overhang adapters so the genomic DNA can be amplyfied (Figure 4). The 16S rDNA 
primers are selected from Klindworth et al. (2013). The full length primer sequences, using 
standard IUPAC nucleotide nomenclature, to follow the protocol: 





Table 1.Amplicon primers and overhangs. 
16S rDNA gene Amplicon PCR Forward Primer CCTACGGGNGGCWGCAG 
16S rDNA gene Amplicon PCR Reverse Primer GACTACHVGGGTATCTAATCC 
Forward overhang 5’ TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG 





Figure 4. 16S V3 and V4 Amplicon workflow. User-defined forward and reverse primers that are 
complementary upstream and downstream of the region of interest. 
3.4.1 PCR PROTOCOL 
The V3-V4 region of the 16S rRNA gene was amplyfied following these steps: 
 
● Mix of a total of 25 µl composed of: 10.5 µl of microbial DNA (1.2ng / µl in 10 mM 
Tris buffer), 1µl "first forward" primer (5 µM), 1µl "first reverse" primer (5 µM) and 
12.5 µl of the Mix 2x KAPA HiFi HotStart polymerase. 
 
● PCR with the following program: 
○ 95 ° C for 3 min  
○ 25 cycles of: 
○ 95 ° C for 30 seconds 
○ 55 º C for 30 seconds 
○ 72 º C for 30 seconds 
 




● Hold at 4 º C  
3.4.2 GEL ELECTROPHORESIS OF PCR AMPLICONS 
 
Afterwards, the clean up is done with AMPure XP beads to purify the 16S V3 and V4 amplicon 
away from free primers and primer dimer species by mixing the dilution of magnetic beads 
(which are attached to DNA fragments that will capture the 16S rRNA sequences by affinity), 
with the resulting PCR amplicons (Figure 5). 
 
The amplified products (the PCR fragments) were also confirmed by gel electrophoresis, using a 
0.8% agarose gel and TBE  5X (Tris/Borate/EDTA) and 2 µl of red gel stain for labelling the 
DNA. At the moment of loading the wells in the solid gel, 10 µl of sample + 2 µl of blue 
loading buffer were mixed in a PCR plate (96 wells). Once the samples were loaded and the 
DNA molecular weight ladders were added, the is set electrophoresis at 100V for 30 min. The 





Figure 5. 16S Library Preparation Workflow. 
 
 3.5.1 INDEX AND PCR TEST 
 
After 16S rDNA gene amplification and cleaning, the mutiplexing step was performed using the 
dual indexing strategy which uses two 8 base indexes, Index 1 (i7) adjacent to the P7 sequence, 
3.5 LIBRARY PREPARATION 
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and Index 2 (i5) adjacent to the P5 sequence. The P5 and P7 sequences are the Illumina 
sequencing adapters that attach to the Illumina flowcell where the clustering and sequencing 
will occur. Dual indexing is enabled by adding a unique combination of Index 1 (i7) and Index 2 
(i5) to each sample by means of a short PCR cycle (2nd Stage PCR in Figure 5).  
 
In order to perform this 2nd Stage PCR, reactions are set up with 5 µl of 16S rRNA amplicon 
product, 5 µl of eavh index, 25 µl of Kappa HiFi Hot Start polymerase and 10 µl of H2O. These 
primers hybridize to the overhang adapters of the 16S rRNA amplicon and include the index 
sequences as well as the P5 or P7 sequences.  
 
The 96 sample Nextera XT Index Kit (FC.131– 1002) uses 12 different Index 1 (i7) adapters 
(N701–N712) and 8 different Index 2 (i5) adapters (S501–S508). In the Index adapter name, the 
N or S refers to Nextera XT sample preparation, and 7 or 5 refers to Index 1 (i7) or Index 2 (i5), 
respectively. Dual index barcodes were added to the amplicon target using the full complement 
of Nextera XT indexes, so that up to 96 libraries could be pooled together for sequencing. The 
12 sequencing libraries corresponding to this work were sequenced jointly with 84 other 
libraries from a different project. After the indexing step AMPure XP beads are used to clean up 
the final libraries before quantification (PCR Clean-Up 2 in Figure 5). After the Clean Up 2 
was done,  the clean 2nd Stage PCR products is ran on a Bioanalyzer DNA 1000 chip to verify 
the size; the expected size of the products on a Bioanalyzer trace is ~550 bp.  
 
3.5.2 LIBRARY QUANTIFICATION AND POOLING 
 
The PCR products were quantified using the Invitrogen Qubit 4 Fluorometer for measuring 
DNA integrity and quality. The kit provides concentrated assay reagent, dilution buffer, and pre-
diluted DNA standards. The reagent is diluted using the provided buffer, sample is added (any 
volume between 1 µl and 20 µl is acceptable), and the DNA concentration is read using the 
Qubit Fluorometer. Illumina recommends quantifying your libraries using a fluorometric 
quantification method that uses dsDNA binding dyes. This allows calculating the DNA 
concentration in nM, based on the size of the DNA amplicons. After quantification, the libraries 
are diluted because the DNA concentrations were too high for the pool. Each library was diluted 
to a concentration of 4 nM using 10 mM Tris pH 8.5. Libraries were pooled by mixing aliquots 
of 5 µl of diluted DNA from each library. Aliquots of the 12 sequencing libraries corresponding 
to this work were mixed with aliquots of 84 other libraries from a different project to be 
sequenced jointly in one MiSeq run.  
 
 
In preparation for cluster generation and sequencing, pooled libraries are denatured with NaOH, 
diluted with hybridization buffer, and then heat denatured before loading into the MiSeq 
platform for sequencing. In addition, the denatured amplicon library must be combined with a 
denatured PhiX control library. Each run must include a minimum of 5% PhiX to serve as an 
internal control. PhiX is a ready-to-use control library, the sequencing of which informs the 
MiSeq software about the coordinates in which the fluorescence associated to the sequencing 
reactions is released. 




The pooled libraries were sequenced on a MiSeq Sequencer at the FISABIO Genomics and 
Health Area, using a 2x300 bp paired-end run with MiSeq Reagent kit v3 (MS-102-3001) 
according to manufacturer’s instructions (Illumina).  
 
During Illumina sequencing, nucleotides are added one by one and only the nucleotide 
complementary to the base of the template sequence is incorporated, emitting a different 
fluorescent light according to the type of nucleotide that has been added. It is a sequencing by 
synthesis. The emitted light signal is detected and with it the sequence. All detected sequences 
are generated as data in the standard FASTQ format. 
 
 
Data have been analyzed using an ad-hoc pipeline written in RStatistics environment (R Core 
Team, 2012), making use of several R Open Source libraries and of the qiime2 platform 
(Caporaso et al., 2010). Qiime2 is a sophisticated and tailored platform that combines numerous 
bioinformatic tools specific for 16S analysis (OTU classification, taxonomic identification, etc).  
 
Quality assessment of sequencing reads was performed with the prinseq-lite program applying 
the following parameters: a minimal read length of 50 nucleotides and a quality score threshold 
of 30, evaluated through a mean quality score computed with a sliding window of 20 
nucleotides. Sequence denoising, paired-ends joining, and chimera depletion was performed 
with the DADA2 software (Callahan et al., 2016). Sequence denoising with DADA2 addresses 
one of the bioinformatics challenges that arise immediately from 16S rRNA sequencing 
analysis, which is the precise definition of a “unique” sequence. DADA2 models and corrects 
Illumina-sequenced amplicon errors (https://github.com/benjjneb/dada2) to infer exact, unique 
sequences, resolving differences of as little as 1 nucleotide. The sequences denoised by DADA2 
can then be grouped into clusters of 100% identical sequences, named Amplicon Single 
Variants (ASV), which can be used as Operational Taxonomic Units (OTU) for further analyses 
(Figure 6). OTUs defined with this 100% identity criterion are clusters of sequences that are 
considered to correspond to the same bacterial strain. 
 




Figure 6. Overview of bioinformatics methods for gut microbiota metagenomic analysis. 
(Ji et al., 2015). 
 
The taxonomic assignment of OTUs can then be inferred by similarity-based or composition-
based methods. In this work, the taxonomic affiliations of the sequences were assigned by 
means of the Naive Bayesian classifier integrated in qiime2 using the SILVA_release_132 
database (Quast et al., 2013) 
 
The Krona representation (Krona hierarchical browser) was used to visualize the microbial 
composition of the different samples (Ondov, et al., 2011). 
 
Diversity within a sample is usually described as alpha-diversity, which captures both the 
organismal richness of a sample and the evenness of the organism’s abundance, whereas the 
beta-diversity is often referred to as the diversity between multiple microbial samples and the 
distance between them, information can be extracted about the similarities between several 
bacterial groups. Diversity analysis is performed using the vegan R library. Vegan is a 
Community Ecology Package for ordination methods, diversity analysis and other functions for 






3.8 BACTERIAL COMMUNITY RICHNESS AND DIVERSITY ESTIMATION 
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3.8.1 ALPHA DIVERSITY INDEXES  
 
For alpha-diversity, richness estimators such as Chao1 (Chao, 1984) are determined, which 
gives us information about the number of species and the richness in a sample. The Chao1 
estimator was chosen because it is suited for estimating total OTU richness in species-rich 
samples. 
 
Moreover, Shannon and Simpson indexes were also studied due to the fact that they also 
consider the microbial distribution. Shannon’s Index is more sensitive to species richness while 
Simpson’s Index is more sensitive to species evenness (Johnson et al., 2016). The Shannon 
index gives us information about the number of species in the sample and the relative 
abundance of each one. It is normally represented as H and is expressed with a positive number, 
which in most cases varies between 0.5 and 5, although its normal value is between 2 and 3; 
values lower than 2 are considered low in diversity and higher than 3 are high in diversity of 
species. The Simpson index gives us information about the probability that 2 individuals of the 
same sample belong to the same species. The number 1 indicates presence of 1 species while a 
number close to 0 indicates more diversity. The information about the heterogeneity inside a 
bacterial community, the number of species and the relative abundance will be shown. 
3.8.2 BETA DIVERSITY INDEXES  
In order to analyze beta diversity, two different parameters were employed, the Jaccard and 
Sorensen indexes. The Jaccard index is a statistic used for gauging the similarity and diversity 
of sample sets so it is a way to compare populations by determining what percent of organisms 
identified were present in both populations. The Sorensen index also compares the similarity 
between samples and is based on presence/absence of data. Both indexes take values from zero 
to one. In a similarity index, a value of 1 means that the two communities you are comparing 
share all their species, while a value of 0 means they share none. In a dissimilarity index the 
interpretation is the opposite: 1 means that the communities are totally different.  
In order to visualized the variation in microbiota composition among samples by means of 
Principal Components Analysis (PCoA) was done using the Jaccard and Sorensen distances. For 
these analyses, data were grouped according to the metadata file provided that specified whether 
samples had been taken before or after in vitro fermentation and the number of days the sample 




4. RESULTS AND DISCUSSION 
 
In this section, the composition of the samples (krona viewer) will be analysed and the 
calculation of the average abundance of different organisms in the different groups of samples at 
the level of family and genus will be done. In order to see the specific bacteria that vary in 
abundance according to the level where you make the comparison. Also, alpha diversity will be 
described before and after fermentation for samples fermented after 0, 8 and 16 days of storage 
at -80 ° C, focusing on the Chao1, Shannon and Simpson indexes. At last, beta diversity will be 
shown with the principal components analysis in order to see differences in taxonomical 
composition among the different groups of samples and what characteristics divide these 
samples in groups. 
 
After the bioinformatic analysis, the results in terms of taxonomic composition for all the 
samples were described in Table 2. There are 12 samples in total, i. e. two repetitions for each 
condition: inoculum and sample after in vitro fermentation for a fresh sample (day 0) and for 
samples having been stored at -80 ° C for 8 or 16 days. This allows us to characterize the effect 
of freezing for different times and how fermentation of bread modifies the intestinal microbiota. 
 
Table 2. Name of the samples and description 
Sample ID Granada_name Description 
S01_1 Pan 1 Fermented bread day 0 
S01_2 Pan 1 Fermented bread day 0 
S02_2 Pan 2 Fermented bread day 8 
S03_1 Pan 3 Fermented bread day 16 
S03_2 Pan 3 Fermented bread day 16 
S04_1 BI 1 Inoculum day 0 
S04_2 BI 1 Inoculum day 0 
S05_1 BI 2 Inoculum day 8 
S05_2 BI 2 Inoculum day 8 
S06_1 BI 3 Inoculum day 16 










4.1.1 COMPOSITION OF THE FRESH INOCULUM  
Generally, the phylum Firmicutes and Bacteroidetes dominate the gut microbial community, 
while members of Proteobacteria, Actinobacteria, Verrucomicrobia, and the candidate phylum 
are less abundant. Even though this general profile remains constant, gut microbiota exhibits 
both temporal and spatial differences in distribution at the genus level and beyond. (Jandhyala et 
al., 2015). To describe the differences in the microbiota profile deriving from different food 
choices, it should be mentioned that Bacteroides was linked to diets that were high in protein 
and animal derived products (mostly omnivorous) and microbiota rich in Firmicutes (which 
includes the enterotype Ruminococcus) was strongly associated with a fat based westernized 
diet and obesity (Filippo et al., 2010). 
 
In Figure 7, the taxonomic composition of the fresh fecal inoculum (S04_1) is ilustrated, so in 
this case there has been no in vitro fermentation with bread or any other food. The phylum 
Bacteroidetes dominates, represented exclusively by the order Bacteroidales, followed by 
Firmicutes, Proteobacteria, Verrucomicrobia and Actinobacteria. Generally, the phyla 
Firmicutes and Bacteroidetes dominate the gut microbial community of healthy adults, while 
members of Proteobacteria, Actinobacteria and Verrucomicrobia are less abundant, 
representing the 17% of the total bacteria. Moreover, Bacteroidetes tends to be more abundant 
than Firmicutes in lean individuals (Ley et al., 2006), as it is described in our fresh sample, 
which is a pool of samples form healthy adults of normal weight.  
 
Bacteroidetes, the major group, is represented by three big genus: Parabacteroides (5% of the 
bacterial community), Alistipes (14%) and Bacteroides (14%). The children from Europe 
normally consume a western diet rich in animal protein, sugar, starch and poor in fibers, which 
is marked by the higher abundance of this phylum. 
 
The second most abundant phylum is that of the Firmicutes (representing 24% of the total 
bacteria) and the main class within this level is Clostridia, which represents the 23% of the total 
composition. This phylum is of interest due to the fact that it shows a large diversity at the 
family level in comparison to other phyla represented in the fresh inoculum. Some of them 
could be highlighted, such as Christensenellaceae, Lachnospiraceae, and Ruminococcaceae, 
being this last one the most abundant (16% of all the microbiota). Members of the Clostridia 
confer to the microbiota the metabolic capacity of degrading complex polysaccharides and of 
fermenting sugars. Thus, they participate in facilitating the absorption and metabolic digestion 






Figure 7. Krona viewer sample S04_2 
(Ondov et al., 2011).  
 
The observed abundance of the phylum Proteobacteria in the fresh inoculum (20%) is within 
the range expected for samples taken from healthy adult individuals. The phylum 
Proteobacteria is generally present in healthy mammalian guts as a normal component of the 
gut microbiota. Under a healthy steady state, the relative abundance of Proteobacteria in the 
human gut can transiently increase to 45% without clinical signs (Caporaso et al., 2011). 
However, a chronic enrichment of Proteobacteria in the gut can represent an imbalanced 
unstable microbial community structure or a state of disease of the host (Shin et al., 2015). 
Under certain conditions, some Proteobacteria can become colitogenic microbes that can 
trigger inflammatory responses. Moreover, dysbiosis during metabolic disorders often includes 
an increased prevalence of Proteobacteria (Shin et al., 2015) and a correlation has been 
identified between the abundance of Proteobacteria and metabolic diseases such as diabetes. 
Within the Proteobacteria, the main class present in the fresh inoculum is 
Gammaproteobacteria and the prevailing family corresponds to Enterobacteriaceae. 
Enterobacteriaceae is a heterogeneous and extensive family of gram-negative bacilli that reside 
in the colon without usually causing disease, but they can often be responsible for a 
considerable number of infections.  
 
Finally, another class to consider is Verrucomicrobiae (17% of the total). This class is usually 
represented specifically by Akkermansia, one of the most abundant genera of the microbiota of 
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the human intestine, generally representing between 1 and 5% of total bacteria. However, in our 
fresh inoculum it is mainly represented by an unidentified uncultured bacterium. Finally, it is 
important to consider the phylum Actinobacteria, which represents the 2% of all the microbial 
community. 
4.1.2 CHANGES IN COMPOSITION OF THE FRESH INOCULUM AFTER BREAD 
FERMENTATION 
Figure 8 presents the krona viewer image for sample S01_1, which corresponds to the unfrozen 
sample after in vitro fermentation with bread. The Bacteroidales and, especially, the Firmicutes 
have become more abundant during the process of bread fermentation, as they now represent 
43% and 37% of the total bacteria in the community, respectively, whereas the phylum 
Proteobacteria has strongly decreased (3%). The Firmicutes class Clostridia is the most 
abundant overall, as it represents 37% of the total bacterial composition. Within this class, the 
family Ruminococcaceae (order Clostridiales) is the most abundant, representing 24% of the 
total bacteria in the sample. Not to mention, it is important to point out the order Bacteroidales 
with a presence representing 43% of all the microbial diversity. In particular, the genera 
Bacteroides and Alistipes represent 23% and 15% of the entire bacterial community, 
respectively. 
 
Considering all other bacterial groups, there is also a high abundance of the class 
Verrucomicrobiae (13% of all bacteria), although the percentage has decreased in comparison to 
the fresh sample before fermentation of bread (17%). Not to mention, higher basal abundance of 
this microorganism is associated with a significant improvement of cardiometabolic parameters 
in subjects with obesity subjected to caloric restriction (Dao et al., 2016). In contrast, the 
relative abundance of the phylum Actinobacteria (4%) has augmented with respect to the 





Figure 8. Krona viewer sample S01_1 
(Ondov et al., 2011). 
 
In conclusion, the fermented samples with bread (S01, S02, S03) display a richer composition 
than the inocula samples without the fermentation process (S04, S05, S06). This could be 
explained with the fact that the process of fermentation allows ceratin microbial species to 
develop and grow in the presence of different foods, in this case, bread composition. On one 
hand, the samples where only the fecal inocula is analysed, the presence of Proteobacteria is 
remarkable and represents half of the microbial composition. Therefore, it is a more 
heterogeneous samples with lower species richness and unbalanced proportions between 
taxonomic groups, dominating Proteobacteria and Firmicutes above all. On the other hand, the 
samples fermented with bread show a bigger abundance of Bacteroidales compared to samples 
S05 and S06 as well as a greater proportion of Firmicutes. In Figure 8, a greater richness is 
visualized, because there is a bigger number of different species and also in similar proportions. 
It is a more heterogeneous sample. Moreover, it a more diverse sample that the S05 because 







4.1.3 CHANGES IN COMPOSITION AFTER SAMPLE STORAGE AT -80 º C. 
 
It is clearly seen that the taxonomical composition of the fecal samples has changed in terms of 
relative taxon proportions after the freezing treatment. It is a significant difference especially in 
terms of the proportion of Proteobacteria, which increase from a relative abundance of 20% in 
the fresh sample to 42% and 56% after 8 days and 16 days of storage at -80 ° C, respectively 
(Figure 9). This increase is accompanied by a substantial decrease in the relative abundances of 





Figure 9. Microbial composition of the inoculum after different times of freezing, 8 days for sample 
S05_1 (left) and 16 days for sample S06_1 (right). 
 
4.1.4 CHANGES IN COMPOSITION AFTER BREAD FERMENTATION WHEN USING 
PREVIOUSLY FROZEN SAMPLES 
 
Figure 10 shows that the samples fermented with bread after having been stored at -80 ° C (S02, 
S03) show an increased abundance of Bacteroidales and Firmicutes compared to the non-
fermented inocula in samples S05 and S06. In contrast, the proportion of Proteobacteria, which 
were greatly over-represented in the inocula prepared from frozen samples, decreases 
substantially after fermentation. Therefore, the main effects seen after bread fermentation are 
the same for these frozen samples as those observed with the fresh sample, i. e., in both cases 
the percentage of Bacteroidales and, especially, that of Firmicutes increases with bread 
fermentation, while that of Proteobacteria decreases. When all samples, fresh and frozen, are 
considered, the differences in the relative abundances of Fimicutes and Proteobacteria between 
the inocula and the fermented samples are highly significant (p=0.081 for both comparisons in 
Wilcoxon tests). However, the difference in the relative abundance of Bacteroidales between 
the inocula and the fermented samples is not significant. 
 
The Verrucomicrobiae also tend to increase with bread fermentation, whereas the proportion of 
Actinobacteria remains similar. These trends are different from those observed with the fresh 
sample for these bacterial groups, since, in that case, the percentage of Verrucomicrobiae 




Figure 10. Microbial composition of samples S02_1 and S03_1, which underwent bread fermentation 
after 8 or 16 days of storage at -80 ° C, respectively. 
 
 
Alpha diversity indexes are generally applied in ecological studies to characterize the number 
and abundance distribution of species, although they are also occasionally used at higher 
taxonomical levels, such as genus or family. Given the difficulty of establishing species 




At family level, the fecal inocula have lower diversity values than the fermented samples, and 
the diversity of the inocula decreases as the freezing time increases as can be seen in Table 3. 
Thus, the alpha diversity in the sample at day 16 of the freezing treatment (S06_1) is 
significantly more reduced than the one at day 0 (S04_1), with a Shannon index of 1.55 and 
2.29, respectively (Table 3).  
 
Furthermore, the range for the Shannon index value is about 0.77 for the inoculum samples 
(S04-S06), whereas the fermented samples show a range of 0.14 among them. From this, it 
could be stressed that the alpha diversity takes more stable values in the samples with the 
fermented bread (S01-S03). This is due to the variation in Shannon index values observed 
between the fresh and frozen inocula, as the index decreases substantially in the latter (Figure 
11). In contrast, diversity is similar for the fermented samples, independently of whether they 
contained fresh or frozen innocula. Regarding the Chao1 index of richness, there are small 
variations of values depending on freezing time. The Chao1 values were slightly reduced with 
the freezing treatment at day 16 (S06_1, Chao1: 35; S06_2, Chao1: 36). The highest Chao1 














Table 3. Estimates of bacterial richness (Chao1 index) and diversity (Shannon and Simpson index) 
comparing the different inoculum and fermented samples at different freezing times at family level. 
 
 CHAO1 Shannon Simpson 
S01_1 39 2.24 0.84 
S01_2 45 2.28 0.85 
S02_2 37 2.17 0.82 
S03_1 43 2.31 0.85 
S03_2 45 2.27 0.85 
S04_1 38 2.29 0.87 
S04_2 37 2.32 0.87 
S05_1 40 1.91 0.75 
S05_2 37 1.82 0.71 
S06_1 34 1.55 0.64 




Figure 11. Chao1, Shannon and Simpson indexes at family level for inoculum and fermented samples. 
 
Once into a more specific taxonomic level, such as the genus level, the differences among the 
samples show different values in terms of richness and diversity. At this level, the Chao1 index 
is much higher in the fermented samples compared to the samples that are only composed of the 
inoculum itself (Figure 12). As an example of this, the fermented sample S01_2 presents an 
index of 125, to be contrasted with the last inoculum sample with freezing treatment at time 16 
(S06_2, Chao1: 79) (Table 4). It is also observed that as the freezing time increases, richness is 
lost and some bacterial genera are disappearing during this treatment. 
 
Regarding diversity indexes such as Shannon, now in a very specific taxonomic group, a great 
diversity of microorganisms can be seen. Focusing on the samples in which there has been 
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fermentation with food, observe an increase in diversity is observed, with values greater than 3 
in S01_1, S01_2, S03_1 and S03_2 (Table 4), which means that the in vitro fermentation 
process has enhanced the appearance of more bacterial groups and has generated a more even 
distribution of organism abundances among these groups. In contrast, for the samples in which 
there has been no in vitro fermentation with bread, values are still below 3, sometimes even 
below 2, as in the case of S06_1, which underwent freezing for 16 days. Again, this indicates 
that the freezing treatment adversely affects both the richness and diversity of the microbiota. 
 
Similarly, the Simpson index shows greater differences between sample values. Before the 
fermentation process the values are between 0.6 and 0.9, whereas after the fermentation the 
values are closer to 1 (Table 4). This means that the fermentation treatment generates a more 
even composition in terms of relative abundance of different microorganisms. In addition, it 
should be pointed out that the cold treatment also has a great influence on the indexes of the 
unfermented inocula. This is seen in the fact that in the inoculum sample at day 0 (without 
freezing treatment) the values of the Simpson index are practically the same as those of the 
samples after fermentation with bread. However, on days 8 and 16 of the freezing treatment it is 
shown that the index is decreasing until reaching 0.66 in S06_1, which shows a direct effect of 
the cold and the loss of microbial diversity. 
 
Table 4. Estimates of bacterial richness (Chao1 index) and diversity (Shannon and Simpson index) 
comparing the different inoculum and fermented samples at different freezing times at genus level. 
 
 CHAO1 Shannon Simpson 
S01_1 120 3.11 0.9 
S01_2 125 3.21 0.91 
S02_2 100 2.99 0.89 
S03_1 122 3.22 0.92 
S03_2 117 3.12 0.91 
S04_1 95 2.83 0.89 
S04_2 92 2.85 0.9 
S05_1 96 2.33 0.78 
S05_2 89 2.26 0.75 
S06_1 80 1.86 0.66 






Figure 12. Chao1, Shannon and Simpson indexes at genus level according to different types of processes. 
 
 
Here, the statistical hypothesis tests in both community composition and microbiome-host 
interactions are discussed. The utility of various statistical approaches for assessing the diversity 
of microbiome communities and analyzing and modelling the association between community 
composition of the microbiome and host are reviewed. 
 
4.3.1 PRINCIPAL COMPONENTS ANALYSIS (PCOA) 
 
To assess beta diversity, principal components analysis was performed with the information 
obtained from the taxonomy analysis.  In PCoA plots, the points that are closer together in the 
graph represent microbial communities that are more similar in taxonomical composition.  
Figure 13 presents a plot of the PCoA analysis performed with taxonomical information at the 
genus level. The first component (dimension 1) clearly divides the inocula (orange ellipse) from 
the fermented samples (green ellipse). This dimension explains 41.7% of the total variation 
among samples.  The second component (dimension 2) explains 22.9% of the variation and also 
clearly separates the unfrozen samples (S01 and S04) from those that have undergone a freezing 




Figure 13. PCoA comparing inoculum and fermented samples. 




Moreover, it can be observed that all technical repetitions plot very closely in the PCoA space. 
It can also be seen that the green ellipse is much wider, indicating that there is more variation 
among samples after fermentation. This is to be expected, since the changes in the microbiota 
are expected to be similar but not necessarily identical in independent fermentation experiments, 
even if the composition of the inocula is very close. 
 
4.3.2 PAIRED WILCOXON TESTS 
 
In Table 5 the relative abundance of a microorganism is compared between the inocula and the 
fermented samples and it is shown whether the difference between the abundance average 
between the two groups is significant (p<0.05). The changes observed for some select genera of 
the Clostridiales families Lachnospiraceae and Ruminococcaceae are reported. For example, 
row number 1 compares the abundance of the Lachnospiraceae genus Eisenbergiella, which is 
more abundant in group 1 (fermented samples) with a mean of 0.0904%, than in group 2 
(inocula) with a mean of 0.022% (p=0.0055). Similarly, it can be highlighted that the relative 
abundances of two other Lachnospiraceae (genus Ventriosum and Xylanophilum group) also 
increase significantly (p=0.0081) in the fermented samples (mean1 = 0.7137 % and 0.1794 %) 
compared to the inocula (mean2 = 0,1064 % and 0,0493 %). Finally, the last row in Table 5 
compares the relative abundance of the Ruminococcaceae genus Butyricicoccus, which is more 
abundant in group 2 (inocula) with a mean of 0.0822 %, than in group 1 (fermented samples) 
with a mean of 0.005% (p=0.0055). 
 
Table 5. Wilcoxon tests between fermented samples (Mean 1) and inocula (Mean 2) by taxa at genus 
level. This Table shows only taxa with significant changes (p-values <=0.05) after doing the Wilcoxon. 
 







1 Firmicutes Clostridia Clostridiales Lachnospiraceae Eisenbergiella 0.0904 0.0022 0.0055 
2 Firmicutes Clostridia Clostridiales Lachnospiraceae Ventriosum 0.7137 0.1064 
 
0.0081 




















Working with human feces need stable methods to ensure the viability of the species and 
conserve them before taking them to the fermentation process. In this project, one of the most 
relevant aims is to see if freezing the samples before fermentation is worth it in order to work 
with them or is it better in fresh. Here is discussed if the results are altered after the fermentation 
once the freezing process is over. 
 
The conclusions that have been reached after this study are: 
 
o It is posible to employ 16S rRNA amplicon sequencing to examine gut microbiota 
oscillations in terms of taxonomy, composition, diversity and richness produced by the 
addition of food (bread) to a fecal inoculum in an in vitro fermentation assay following 
in vitro food digestion. Moreover, this result demonstrates that in vitro fermentation 
experiments can be used to analyze the effects of diverse foods on fecal microbial 
communities, in order to provide valuable information to design personalised diets that 
modulate an individual’s gut microbiota. 
o The samples fermented with bread display a richer and more diverse composition than 
the inocula samples without the fermentation and there is an increase in the phylum 
Firmicutes and a decrease in the phylum Proteobacteria. 
 
o Freezing the fecal sample before in vitro fermentation assays has significative effects on 
the composition and diversity of the inoculum. There is a disturbance in the taxa due to 
the freezing treatment and the alpha diversity is reduced. 
 
o Nevertheless, in spite of the effects of the freezing treatment, the microbial community 
in the frozen inocula is modified by the fermentation process in a similar manner to 
what is observed in fermentation assays with fresh samples. 
 
In the end, despite losing bacterial species and altering the microbial composition, it is not so 
serious to freeze because the effect of fermentation among the samples remains significant in 
terms of richness and diversity. 
 
 
The gastrointestinal microbiome is an essential contributor to mammalian health that 
participates in vital physiological processes and guides host development. Abnormalities in gut 
microbial populations have been associated with a variety of gastrointestinal and systemic 
diseases, making the intestinal microbiome a viable diagnostic and therapeutic target. While 
recent advances in DNA sequencing and computational technology have revolutionized the field 
of microbiomics, many fundamental questions remain unanswered. Future directions for 
research should aim to elucidate the mechanisms underlying interactions between the 
microbiome and host, describe the process of microbiome maturation during host development 
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and its impact on early-life and adult health outcomes, clarify its role in the pathogenesis of 
disease states, and assess the viability of diagnostic tests and therapies designed to assess and 
treat conditions associated with intestinal alterations such as non-communicable diseases, 
including cancer and metabolic-related disease. 
 
Not to mention, diet continues to be the most important determinant in shaping the composition, 
diversity and richness even throughout adulthood. In the last decade, the microbiome field has 
made tremendous strides in identifying a link between microbiome and diet. However, there are 
many technological limitations and challenges in meta-omic technologies, bioinformatics 
analyses and lack of experimental models which have created barriers for microbiome research. 
What is more, most microbiome clinical studies have been cross-sectional and performed with 
little or no attention to critical clinical metadata (host physiology, disease subtype stratification, 
age, race, demography, and other biological variables). Consequently, large amounts of 
observational data with limited mechanistic insights have been generated. Moreover, given the 
tremendous inter-individual variation in human gut microbial composition and function, it is 
unclear to what level these types of studies need to be powered in order to gain better insight.  
 
The analysis of microbial community diversity is rapidly becoming a component of a vast array 
of different research programs, ranging from neurobiology to nutrition. Personalised nutrition 
strategies based on individual gut microbiome features are recently emerging and in a next 
future will allow developing new therapeutic or disease-preventive approaches based on a 
targeted modulation of gut microbiome through diet (Barko et al., 2018). However, the 
development of innovative technologies and sophisticated bioinformatics tools that integrate the 
data from both host and microbiome will be necessary to make precision nutrition through the 
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Table 1. Bread composition in nutriets, values for 100g. 
 
 
